Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

Published:2016-01 Issue:1 Volume:27 Page:185-192
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Takeuchi K.,Togashi Y.,Kamihara Y.,Fukuyama T.,Yoshioka H.,Inoue A.,Katsuki H.,Kiura K.,Nakagawa K.,Seto T.,Maemondo M.,Hida T.,Harada M.,Ohe Y.,Nogami N.,Yamamoto N.,Nishio M.,Tamura T.

Funder

Chugai Pharmaceutical Co. Ltd

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/1/185/16702008/mdv501.pdf

Reference16 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

3. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts;Takeuchi;Clin Cancer Res,2008

4. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer;Takeuchi;Clin Cancer Res,2009

5. Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance;Kodama;Cancer Lett,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of Resistance Mechanisms to ALK TKIs in NSCLC: Largest Single-Center Experience from India;South Asian Journal of Cancer;2024-05-29

2. Immunohistochemistry of Lung Cancer Biomarkers;Advances in Anatomic Pathology;2024-04-26

3. Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations;Cancers;2024-01-22

4. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing;International Journal of Clinical Oncology;2024-01-06

5. Prognostication Using the Japanese Risk Calculator for Lung Cancer Surgery;Clinical Lung Cancer;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3